A carregar...
Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction
Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma (HCC). Only one case of radiation recall dermatitis (RRD) associated with sorafenib has been reported so far. Our patient with recurrent HCC was treated with palliative radio...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Society for Radiation Oncology
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3797277/ https://ncbi.nlm.nih.gov/pubmed/24137563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3857/roj.2013.31.3.171 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|